| Application no. and date | 14874081.4 (espacenet) (Federated) (European Patent Register), 20141224 | | Patent/reg. no. and date | DK/EP 3087183, 20200826 | | Publication date | 20161102 | | Priority no. and date | US 201361920652 P, 20131224 | | EP pub. no. and date |
EP 3087183 20161102 | | Effective date | | | Applicant/owner | Ionis Pharmaceuticals, Inc., 2855 Gazelle Court
Carlsbad, CA 92010, US | | Applicant ref. no. | P74139DK01 | | Inventor | FREIER, Susan, M., 2855 Gazelle Court
Carlsbad, CA 92010, US,
CROOKE, Rosanne, M., 2855 Gazelle Court
Carlsbad, CA 92010, US,
GRAHAM, Mark, J., 2855 Gazelle Court
Carlsbad, CA 92010, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C12N 15/113 (2010.01) | | Title | MODULATION AF ANGIOPOIETIN-3-LIGNENDE EKSPRESSION | | Int. application no. | US2014072303 | | Int. publication no. | WO2015100394 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
